Covered recipient · General Payments record
JANA GRIER
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$630.69
- Reported across 35 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $205.20 | 10 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $70.15 | 4 |
| Ardelyx, Inc. | $32.08 | 1 |
| ABBVIE INC. | $28.72 | 1 |
| Xeris Pharmaceuticals, Inc. | $21.17 | 1 |
| Mylan Specialty L.P. | $20.34 | 1 |
| Exact Sciences Corporation | $19.44 | 1 |
| Acerta Pharma LLC | $13.30 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $28.72 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107254209 | CMS |
| Ardelyx, Inc. | $32.08 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146728690 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.30 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104451170 | CMS |
| Exact Sciences Corporation | $19.44 | 03/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114683453 | CMS |
| Mylan Specialty L.P. | $20.34 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147296757 | CMS |
| Novo Nordisk Inc | $17.07 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100247087 | CMS |
| Novo Nordisk Inc | $14.76 | 03/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100548914 | CMS |
| Novo Nordisk Inc | $23.85 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100355648 | CMS |
| Novo Nordisk Inc | $14.47 | 06/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100600361 | CMS |
| Xeris Pharmaceuticals, Inc. | $21.17 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144627916 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.